Acustis – Trademark Portfolio

Entity Type: 99

Acustis holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 42 (Computer & Scientific) — 2 filings in this category. The portfolio also extends into Class 9 (Computers & Electronics) across 3 Nice Classification classes. Currently, 2 trademarks are registered. Notable registered marks include ACUSTIS.

13 rue Marmontel

F-75015 Paris

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark
Serial #79256150
Registered 2019
ACUSTIS
ACUSTIS
Registered 2019

Trademark Classifications

Acustis's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

42
Computer & Scientific (2 filings)

Scientific and technological services; industrial analysis and research services

9
Computers & Electronics (2 filings)

Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does Acustis have?

Acustis has 2 U.S. trademarks filed with the USPTO. Of these, 2 registered.

What trademark classes does Acustis file in?

Acustis files trademarks across 3 Nice Classification classes. The most active classes are Class 42 (Computer & Scientific), Class 9 (Computers & Electronics), Class 10 (Medical Apparatus). Class 42 covers scientific and technological services; industrial analysis and research services.

What are Acustis's most well-known trademarks?

Acustis's registered trademark portfolio includes well-known marks such as ACUSTIS. These are among 2 currently registered trademarks in the portfolio.

What is Acustis's trademark registration success rate?

Acustis has a 100% trademark registration rate, with 2 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.